Indivior (INDV) Announces Board Changes

Indivior PLC (NASDAQ: INDV) ("Indivior" or the "Company") today announced that, further to the announcement on December 17, 2024 of certain Director arrangements agreed with Oaktree Capital Management L.P. ("Oaktree"), the announcement on January 28, 2025 of the appointment of Dr. David Wheadon as Chair of the Company, the announcement on February 3, 2025 of the appointment of Daniel Ninivaggi as an Independent Non-Executive Director of the Company, and the announcement on February 27, 2025 of the appointment of Joe Ciaffoni as Chief Executive Officer of the Company, and following further discussions with Oaktree, the Company has agreed to make certain further changes to its Board of Directors (the "Board"):

• The Company will reduce the size of its Board to seven directors as of the 2025 Annual General Meeting ("AGM"), each of whom will stand for re-election at the upcoming AGM;
• Consistent with the Company's switch to a US primary listing in 2024, Peter Bains and Jo LeCouilliard have decided not to stand for re-election at the AGM;
• Robert Schriesheim has stepped down as an Independent Non-Executive Director effective from March 2, 2025;
• The Company will commence a search for one new Independent Non-Executive Director, the identity of whom shall be subject to Oaktree's approval, and whose appointment shall be confirmed by July 1, 2025, failing which Oaktree will have the ability to nominate a further Non-Executive Director to the Board. This will bring the number of directors to eight after the AGM;
• Daniel Ninivaggi will be appointed Chair of the Nomination Committee, effective March 10, 2025;
• Barbara Ryan will succeed Jo LeCouilliard as Chair of the Compensation Committee, effective from the end of the AGM; and
• The Company's Operational Committee will be discontinued.

Dr. David Wheadon, Chair said, "Peter Bains, Jo LeCouilliard and Rob Schriesheim have been unswerving in their support of bringing needed therapeutic interventions to patients suffering from opioid use disorder. I sincerely thank them for the service they have given to Indivior."

In connection with these changes, Indivior and Oaktree have entered into an amended and restated Relationship Agreement, which contains, among other items, customary obligations and undertakings of mutual support.

You May Also Be Interested In

• Cloudastructure grows sales team by 30% to meet enterprise demand
• Stitch Fix adds self-image feature to its AI styling platform
• Nebius selects Komodor platform for Kubernetes reliability ops